Which drugs may cause hypoglycemia for enterally fed patients?

Hypoglycemia in enterally fed patients can be influenced by several medications, making the correct answer an important consideration in gerontological nutrition practice.

Each of the mentioned drug classes can interact with insulin levels or glucose metabolism in a way that could lead to a decreased blood sugar level. For example, sulfonamides are known to promote insulin secretion, which can lower blood glucose, especially in individuals who may already be receiving glucose through enteral feeding. Similarly, propranolol, a beta-blocker, can interfere with the body's normal response to hypoglycemia, masking symptoms and potentially contributing to lower glucose levels.

Moreover, barbiturates can affect the liver’s ability to store and release glucose, while MAOIs (monoamine oxidase inhibitors) have complex interactions with many neurochemicals that may indirectly influence glucose metabolism. Acetaminophen, while primarily known for its analgesic and antipyretic properties, can also impact glucose levels in certain contexts.

The combination of these medications could collectively create a condition where hypoglycemia is a risk for patients receiving enteral nutrition. Therefore, recognizing that all these drug classes can contribute to lower blood sugar levels underscores the need for careful monitoring and management of blood glucose in enterally fed